New Algorithm Predicts Prostate Cancer Recurrence for Radiation Therapy Patients
Researchers developed a patent-pending method and algorithm to predict prostate cancer recurrence in patients treated by radiation therapy.
Read MorePosted by Andy Lundin | Oct 9, 2023 | Prostate |
Researchers developed a patent-pending method and algorithm to predict prostate cancer recurrence in patients treated by radiation therapy.
Read MorePosted by Andy Lundin | Oct 2, 2023 | Prostate |
Black patients seen by a precision medicine navigator were substantially more likely to receive genomic testing than those who were not.
Read MorePosted by Andy Lundin | Aug 15, 2023 | Prostate |
To explore why prostate cancer disproportionately harms Black men, researchers looked to another disorder, diabetes, which alters metabolism.
Read MorePosted by Andy Lundin | Aug 8, 2023 | Prostate |
Biomarkers of significant prostate cancer that are detected in urine or blood tests are desperately needed to help reduce prostate biopsies.
Read MorePosted by Andy Lundin | Jul 18, 2023 | Prostate |
Quest launched a prostate cancer biomarker test through its pathology business, AmeriPath, in collaboration with Envision Sciences.
Read More